Topics

Transgene - TG4001 first efficacy data presented at ESMO

09:58 EDT 4 Oct 2019 | FinanzNachrichten

At the 2019 European Society for Medical Oncology (ESMO) conference, Transgene presented the first efficacy data for TG4001 in combination with avelumab (Bavencio) in patients with human papillomav...

Original Article: Transgene - TG4001 first efficacy data presented at ESMO

NEXT ARTICLE

More From BioPortfolio on "Transgene - TG4001 first efficacy data presented at ESMO"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...